Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin

作者: Satoshi Yokoyama , Yasuhiro Sugimoto , Chihiro Nakagawa , Kouichi Hosomi , Mitsutaka Takada

DOI: 10.1038/S41598-019-53392-Y

关键词: CancerOdds ratioReceptorProstateMedicineAdverse Event Reporting SystemDrug repositioningPharmacologyDigoxinBioinformatics databases

摘要: Cardiac glycosides, such as digoxin, inhibit Na+/K+-ATPases and cause secondary activation of Na+/Ca2+ exchangers. Preclinical investigations have suggested that digoxin may anticancer properties. In order to clarify the functional mechanisms in cancer, we performed an integrative analysis clinical bioinformatics databases. The US Food Drug Administration Adverse Event Reporting System Japan Medical Data Center claims database were used databases evaluate reporting odds ratios adjusted sequence ratios, respectively. BaseSpace Correlation Engine Connectivity Map investigate molecular pathways related mechanisms. Clinical analyses inverse association between four cancers: gastric, colon, prostate haematological malignancy. exert effect via peroxisome proliferator-activated receptor α apoptotic caspase cascade pathways. Our revealed possibility a drug repositioning candidate for cancers.

参考文章(50)
Krzysztof Bielawski, Anna Bielawska, Katarzyna Winnicka, Cardiac glycosides in cancer research and cancer therapy. Acta Poloniae Pharmaceutica. ,vol. 63, pp. 109- 115 ,(2006)
Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching-Hsiung Lin, Min-Hsuan Chen, Gee-Chen Chang, Meng-Feng Tsai, Jeremy J. W. Chen, Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer PLOS ONE. ,vol. 10, pp. e0123305- ,(2015) , 10.1371/JOURNAL.PONE.0123305
Alexandra Drakaki, Maria Hatziapostolou, Christos Polytarchou, Christina Vorvis, George A. Poultsides, John Souglakos, Vassilis Georgoulias, Dimitrios Iliopoulos, Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer. ,vol. 15, pp. 542- 542 ,(2015) , 10.1186/S12885-015-1562-9
Sten Orrenius, Boris Zhivotovsky, Pierluigi Nicotera, Regulation of cell death: the calcium-apoptosis link. Nature Reviews Molecular Cell Biology. ,vol. 4, pp. 552- 565 ,(2003) , 10.1038/NRM1150
Izyan A. Wahab, Nicole L. Pratt, Michael D. Wiese, Lisa M. Kalisch, Elizabeth E. Roughead, The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiology and Drug Safety. ,vol. 22, pp. 496- 502 ,(2013) , 10.1002/PDS.3417
Thomas P Ahern, Timothy L Lash, Henrik T Sørensen, Lars Pedersen, None, Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Research. ,vol. 10, pp. 1- 8 ,(2008) , 10.1186/BCR2205
Y. A. Lussier, J. L. Chen, The Emergence of Genome-Based Drug Repositioning Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3001512
Francesco Iorio, Timothy Rittman, Hong Ge, Michael Menden, Julio Saez-Rodriguez, Transcriptional data: a new gateway to drug repositioning? Drug Discovery Today. ,vol. 18, pp. 350- 357 ,(2013) , 10.1016/J.DRUDIS.2012.07.014
Xiaoyan A. Qu, Deepak K. Rajpal, Applications of Connectivity Map in drug discovery and development. Drug Discovery Today. ,vol. 17, pp. 1289- 1298 ,(2012) , 10.1016/J.DRUDIS.2012.07.017
Jesper Hallas, David Gaist, Lars Bjerrum, The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization Epidemiology. ,vol. 8, pp. 666- 670 ,(1997) , 10.1097/00001648-199710000-00009